Barcelona, Spain

Javier Martinez

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Azienda Ospedaliera Universitaria Senese. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Javier Martinez. Retrieved from https://idiyas.com/inventor/javier-martinez-dlzn9o1l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Javier Martinez: Innovator in Therapeutic Agents

Introduction

Javier Martinez is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of therapeutic agents, particularly in the development of compounds that inhibit RNA helicase DDX3. His work is particularly relevant for the treatment of viral diseases.

Latest Patents

Martinez holds a patent for "Human helicase DDX3 inhibitors as therapeutic agents." This invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity, which are crucial for developing new treatments for viral infections. He has 1 patent to his name, showcasing his innovative approach to addressing medical challenges.

Career Highlights

Throughout his career, Javier has worked with esteemed organizations such as Azienda Ospedaliera Universitaria Senese and Helmholtz-Zentrum für Infektionsforschung GmbH. His experience in these institutions has allowed him to refine his research and contribute to significant advancements in therapeutic applications.

Collaborations

Martinez has collaborated with notable colleagues, including Andreas Meyerhans and Miguel Angel Martinez De La Sierra. These partnerships have enriched his research and expanded the impact of his inventions in the scientific community.

Conclusion

Javier Martinez is a distinguished inventor whose work in developing DDX3 inhibitors has the potential to transform the treatment of viral diseases. His contributions to the field highlight the importance of innovation in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…